Owlet, a leader in smart infant monitoring, has announced the expanded availability of its medically-certified Dream Sock across Europe. The announcement was made at Kind + Jugend, a major trade show in Cologne, Germany, where Owlet showcased the Dream Sock and shared its plans to make the device accessible in additional European countries, including Poland, Greece, and the Czech Republic.
The Dream Sock is Owlet’s baby monitor, which provides parents with real-time health readings and actionable alerts while their baby sleeps. This device, which has already been a game-changer for thousands of families since its global launch, is now set to reach even more parents worldwide.
“Dream Sock has already made a huge impact on thousands of families since its global launch a few months ago, and we are eager to continue the roll-out of our medical-grade technology to even more parents,” said Kurt Workman, Owlet Chief Executive Officer and Co-Founder.
The Dream Sock, which is CE and UKCA Marked under EU and UK Medical Device Regulations, meets stringent regulatory standards, ensuring its safety, efficacy, and compliance with all necessary requirements. This smart infant monitoring device wraps comfortably around a baby’s foot and monitors vital signs such as pulse rate, oxygen saturation level, and sleep patterns. These readings are delivered in real-time to the Owlet Dream App, available on iOS and Android, as well as to the included Base Station. Both the app and Base Station immediately alert caregivers if the baby’s vital signs fall outside of the normal range.
Currently available for purchase in the UK and select European markets, the Dream Sock will soon be available in Poland, the Czech Republic, Slovakia, Hungary, Romania, Bulgaria, and Greece through Owlet’s localized websites and key retailers.
